drugset / Trial / NCT01062360

Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine

NCT01062360

Phase 3 Completed 1016 enrolled Bayer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is compare efficacy and tolerability of a fixed combination, containing 500 mg Acetylsalicylic acid and 30 mg Pseudoephedrine, in comparison to its single components in patients with sore throat and nasal congestion.

Timeline

Start
2005-12-23
Primary completion
2007-05-14
Completion
2007-05-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 500 mg Oral
Comparator Pseudoephedrine Small molecule 30 mg Oral

Indications